Prothena Corporation 2024 Corporate Overview

Prothena Corporation is a clinical-stage biotechnology company focused on developing therapies for diseases caused by protein dysregulation. The presentation outlines the company's pipeline including programs like birtamimab, prasinezumab, NNC6019, and BMS-986446, with expected clinical trial updates planned for 2024-2025. The company has partnerships with major pharmaceutical firms including Roche, BMS, and Novo Nordisk.